FMS is dominant primarily in women (3-5%). FMS is characterized by physical symptoms of muscle pain, chronic fatigue and non-restful (alpha) sleep. Most sufferers of FMS experience depression (>70%), anxiety (24%) and cognitive problems of "Fibro-fog" (a slow alpha brainwave condition).

Three groups totaling 49 participants were randomly selected and placed into an AVE, medical treatment or nutrition group. Participants were taken from Dr. Seibel's patient list. During the first month all participants received individual treatments and during the second month, received all treatments combined. Participants were assessed on a SCL-90 personality test. The AVE group showed better improvements than the medical and nutritional groups (see graph). Participants used the AVE as follows; 1) Delta stimulation at bedtime for sleep; 2) Alpha sessions in the afternoon - for anxiety, and; 3) Beta sessions upon awakening - for a clear mind.